Opthea Limited (OPTEY) Stock
OPTEY is no longer traded. Opthea was delisted from the Nasdaq in July 2026.
Prices on this page are historical; the last trade was July 22, 2026 at $0.03.
Opthea stock price history
OPTEY final trading statistics
- Final close
- $0.03
- Final trading day
- Jul 22, 2026
- Market cap at delisting
- $5.81M
- Shares outstanding
- 171.00M
- Final 52-week range
- $0.00 – $3.41
- Avg. volume (final 3 mo.)
- 26,068
- All-time high (split-adj.)
- $21.36 · Jan 2020
- All-time low (split-adj.)
- $0.01 · Jan 2026
- Return since IPO
- -99.1%
- Beta
- 1.53
- Book value / share
- $0.14
- Price / book
- 0.25
Opthea annual financials
| Fiscal year | Revenue | Net income | EPS |
|---|---|---|---|
| FY2025 | $25.0K | -$162.8M | -$0.14 |
| FY2024 | $125.0K | -$220.2M | -$2.80 |
| FY2023 | $108.0K | -$142.5M | -$2.10 |
| FY2022 | $90.7K | -$92.8M | -$0.37 |
Last five fiscal years reported before the delisting; fiscal year ending June. EPS is adjusted (non-GAAP) EPS as reported. Source: company filings via EODHD.
About Opthea Limited
Ceryvyn Therapeutics Limited, a clinical-stage biopharmaceutical company, researches and develops therapeutic products based on targeting vascular endothelial growth factors (VEGF) C, D and R3 in Australia and the United States. The company's pipeline includes Sozinibercept, which is in phase 3 to treat wet age-related macular degeneration (Wet AMD), as well as in phase 2 to treat diabetic macular edema (DME). It serves the biotechnology and healthcare industries. The company was formerly known as Opthea Limited and changed its name to Ceryvyn Therapeutics Limited in July 2026. Ceryvyn Therapeutics Limited was incorporated in 1984 and is headquartered in Melbourne, Australia.
Opthea stock FAQ
What happened to Opthea stock?
Opthea stock was delisted from the Nasdaq. Its final close was $0.03 on July 22, 2026.
Is OPTEY stock still trading?
No. OPTEY was delisted from the Nasdaq in July 2026 and no longer trades on a U.S. exchange.
What was the last price of OPTEY stock?
OPTEY closed at $0.03 on its final trading day, July 22, 2026, for a market value of about $5.81M.
What were Opthea's revenue and earnings in its last full fiscal year?
Opthea reported revenue of $25.0K and net income of -$162.8M in fiscal 2025, its last full year as a public company.
When did Opthea go public?
Opthea Limited stock began trading on April 12, 2012.